Cooper et al v. Wyeth, Inc et al
Filing 163
ORDER granting 149 Motion for Reconsideration. The Court's Ruling of 03/06/2012, is hereby AMENDED for the reasons set forth above, and Plaintiffs' remaining claims against Defendants PLIVA, Inc. and Watson Laboratories, Inc. for failure to warn under the Louisiana Products Liability Act (LPLA), based on the theories of failure to communicate and update to include an FDA-approved label on their generic drug products are hereby DISMISSED with prejudice. This Ruling has no bearing on Plaintiffs' remaining claims against Defendant, Wyeth LLC, individually and as successor-in-interest to ESI-Lederle, Inc. Signed by District Judge Shelly D. Dick on 12/11/2013. (CGP)
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
